## Abstract Arg^34^Lys^26^(__N__^ε^‐(γ‐L‐glutamyl(__N__^α^‐palmitoyl)))‐GLP‐1(7‐37) (NN2211) is currently in development as a diabetes type 2 drug. The fatty acid attached to the GLP‐1(7‐37) ensures a long and controlled duration of action. The synthesis of [^125^I]NN2211, [^127^I]NN2211 and [^14^C
✦ LIBER ✦
[125I]- and [14C]-labelling of the long-acting insulin derivative NN304
✍ Scribed by Jesper B. Kristensen; Lars K. Müller; Ulla D. Larsen; Louis B. Hansen; Christian Foged
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 372 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
[125I], [127I]-and [14C]-Labelling of th
✍
Jesper B. Kristensen; Mette L. Pedersen; Ulla D. Larsen; Lars Martiny; Louis B.
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
French
⚖ 121 KB
The synthesis of the carbonyl-14C analog
✍
Douglas D. O'Bannon; William J. Wheeler
📂
Article
📅
1991
🏛
John Wiley and Sons
🌐
French
⚖ 319 KB
## Abstract __Endo__‐5‐chloro‐2,3‐dihydro‐2,2‐dimethyl‐N‐(8‐methyl‐8 ‐azabicyclo‐[3.2.1.]‐oct‐3‐yl‐7‐benzofurancarboxamide‐[carbonyl‐^14^C] (Z)‐2‐butenedioate (zatosetron‐[^14^C] maleate, 1), has been prepared from 5‐chloro‐7‐bromo‐2,3‐dihydro‐2,2‐dimethylbenzofuran (5) in four radiochemical steps